On August 1, 2023 Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, reported that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1×1 investor meetings at the Canaccord Genuity 43rd Annual Growth Conference, which will be held from August 7-10, 2023 (Press release, Biodesix, AUG 1, 2023, View Source [SID1234633579]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Canaccord Genuity 43rd Annual Growth Conference
Fireside Chat Date: Wednesday, August 9, 2023
Fireside Chat Time: 4:00 PM ET
Location: InterContinental Boston, Boston, MA

The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of Biodesix’s website at Biodesix.com.